MedTrace Logo

4P Study: Predictive Quality With Painfree Therapies

NCT01509378 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2025-07-03

No results posted yet for this study

Summary

The aim of the study is to characterize and quantify the relative effectiveness and contribution of implantable cardioverter defibrillator (ICD) therapy to the clinical outcomes under the conditions of daily practice.

Swiss, multicenter, prospective, observational study.

Conditions

Sponsors & Collaborators

  • Medtronic

    collaborator INDUSTRY

  • Medtronic Cardiac Rhythm and Heart Failure

    lead INDUSTRY

Principal Investigators

  • Martin Fromer, Professor · CHUV, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland

  • Mayella Favre · Medtronic (Suisse) SA

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-11-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01509378 on ClinicalTrials.gov